Filter
118
Filtered Results: 118
Text search:
Priotto,
G.
Featured
Recommendations
11
Language
Document type
Studies & Reports
47
Guidelines
37
No document type
17
Manuals
7
Training Material
4
Strategic & Response Plan
3
Fact sheets
2
Situation Updates
1
Countries / Regions
Africa
11
Global
9
South Africa
6
India
4
Kenya
3
West and Central Africa
3
East and Southern Africa
3
Uganda
3
Rwanda
2
Syria
2
Nigeria
2
Guinea
2
Latin America and the Carribbean
2
Germany
2
Middle East and North Africa
2
United Kingdom
2
Bangladesh
2
Ethiopia
2
Eswatini/ Swaziland
2
Colombia
1
Cameroon
1
Senegal
1
Zimbabwe
1
Philippines
1
Haiti
1
Tanzania
1
Congo, Democratic Republic of
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Portugal
1
Spain
1
Azerbaijan
1
Israel
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Brazil
1
Moldova
1
Angola
1
Chad
1
Zambia
1
South Sudan
1
Somalia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Guidelines
13
Studies & Reports
9
COVID-19
5
Women & Child Health
4
Statistics
4
Policies
3
Immunization
3
Gynaecology & Obstetrics
3
Vector Control
2
Cervical Cancer
2
Maternal & Child Health
2
Pediatrics
2
NCD
2
Policies & Guidelines HIV & TB
2
Capacity Building
2
Surgery & Anaesthesia
2
Human African Trypanosomiasis
2
Disease Prevention & Control
2
Reproductive Health
2
Communicable Diseases
1
Virology
1
Infection Control & Prevention (IPC)
1
Snakebites
1
Hemorrhagic Fever
1
Child protection
1
Demograhic Health Surveys DHS
1
Drugs & Medical Equipment
1
Community Health
1
Disabilities
1
Mental Health
1
Female Genital Mutilation
1
Health Systems
1
Nutrition
1
Maternal Health
1
Non-communicable Diseases
1
HIV & STI
1
Malaria
1
TB
1
Toolboxes
Studies & Reports
8
Clinical Aspects & Diagnostics
6
Country specific documents
5
Surveillance
4
Country specific
3
Paediatrics
2
Child Protection
2
Overview & reports
2
General documents One Health
2
Climate Change
2
Snakebite envenoming
2
Assessment & Response
2
Outbreak Prevention & Control
1
Treatment Guidelines
1
ART Drug Resistance
1
Intellectual Disability
1
Laboratory Guidance
1
Children with Disabilities
1
HIV testing & services
1
Europe
1
Treatment & Prevention
1
Prevention & Control
1
Early Warning
1
Adults
1
Zambia
1
Children
1
Public Health
1
mhGAP Guides
1
Children with disabilities
1
Drug resistance
1
General Studies & Reports
1
Cholera Prevention & Control
1
Workplace
1
International
1
Treatment Guidelines
1
Clinical Guidelines
1
Supporting tools
1
Studies
1
Health Personnel
1
General
1
PPE Personel Protective Equipment
1
Infection Control General
1
Diagnostics & Laboratory Guidance
1
For Pregnant Women
1
Clinical Guidelines
1
Country Specific
1
Global Impact: Socio-economic, health services, TB & HIV
1
Child Protection
1
Gender Aspects
1
Subsidiarity
1
HIV and COVID-19
1
Essential Medicines & Medical Devices
1
Logistics & Supply
1
Fair Allocation & Ethical Aspects
1
Genomic sequencing
1
Biontech/Pfizer Comirnaty
1
Hygiene
1
Others
1
Studies & Reports
1
Community Health Workers CHW
1
Nurses
1
Urban health
1
Essential Medicines & Devices Lists
1
Traditional & Herbal Medicines
1
HIV &TB
1
Pediatrics
1
Surgery
1
Land-system change
1
Biogeochemical flows
1
Antimicrobial Resistance (AMR)
1
Infectious Diseases
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Studies & Reports
1
Policies & Strategies
1
Onchocerciasis
1
General Information
1
General Information & Methodology
1
Global Overview
1
Clinical Guidelines
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Hearing Loss & Deafness
1
Autism
1
Protection
1
Assessment & Response
1
TB & Prisoners
1
Mental disorders, others
1
Policy
1
Training
1
Nutrition
1
Anxiety Disorders
1
AmR (Region of Americas)
1
MHPSS Guidelines
1
Depression
1
Preparedness & Prevention
1
Early detection, assessment and response to acute public health events:
Mise en oeuvre de l’alerte précoce et réponse notamment la surveillance fondée sur les évènements
Cervical cancer, along with maternal deaths, has been identified as a national priority in
South Africa as well as other Sub-Saharan African countries. Cervical cancer is the
second most common cancer among women in South Africa, after breast cancer. Due
to limited access to prevention, early dia...
The WHO Framework Convention on Tobacco Control (WHO FCTC) is an evidence-based treaty that reaffirms the right of all people to the highest standard of health and was developed in response to the globalization of the tobacco epidemic. Member States of the WHO South-East Asia Region have made...
Globally, 311,000 women die of cervical cancer every year, 85 percent of them
in resource limited regions of the world. To address this grave threat to women,
the WHO made a call to action in 2018, resulting in accelerated plans to improve
cervical cancer control under the elimination threshold w...
At the forefront of DNDi’s efforts to develop new treatments is the need to understand the realities and treatment needs of patients and health care staff in the field. The ultimate goal for human African trypanosomiasis (HAT) is a truly simplified
treatment which can be orally administered, impl...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diagnostic tools and strategies were introduced into South Sudan, as part of integrated delivery of primar...
Un comité OMS d’experts sur la trypanosomiase humaine africaine (THA) : lutte et surveillance, s’est réuni à Genève (Suisse), du 22 au 26 avril 2013. Le Dr H. Nakatani, sous-directeur général pour le VIH/SIDA, la tuberculose, le paludisme et les maladies tropicales négligées, a ouvert la...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face significant difficulties of diverse natures.
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan ...
This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related noncommunicable diseases in adults and children. The guidance in this guideline is not based on toxicological assessments of the safety of individual no...
The COVID-19 pandemic has been the biggest disaster in living memory, on almost any measure. More than 6.5 million people are confirmed to have died in less than three years, and the pandemic’s indirect impacts have touched the lives of virtually every community on the planet.
Our World Disasters...
Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20·0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spe...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
